1
|
Hirsch E, Bornemissza Z, Nagy ZK, Marosi GJ, Farkas A. Quantitative and qualitative analysis of cell culture media powders for mammalian cells by Raman microscopy. SPECTROCHIMICA ACTA. PART A, MOLECULAR AND BIOMOLECULAR SPECTROSCOPY 2024; 310:123906. [PMID: 38277781 DOI: 10.1016/j.saa.2024.123906] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Revised: 11/23/2023] [Accepted: 01/15/2024] [Indexed: 01/28/2024]
Abstract
Cell culture media are essential for large-scale recombinant protein production using mammalian cell cultures. The composition and quality of media significantly impact cell growth and product formation. Analyzing media poses challenges due to complex compositions and undisclosed exact compositions. Traditional methods like NMR and chromatography offer sensitivity but require time-consuming sample preparation and lack spatial information. Raman chemical mapping characterizes solids, but its use in cell culture media analysis is limited so far. We present a chemometric evaluation for Raman maps to qualify and quantify media components, evaluate powder homogeneity, and perform lot-to-lot comparisons. Three lots of a marketed cell culture media powder were measured with Raman mapping technique. Chemometrics techniques have outlined a strategy to extract information from complex data. First, a spectral library has been structured. In addition to the 23 spectra for presumed ingredients, we obtained another 9 pure components with Multivariate Curve Resolution-Alternating Least Squares (MCR-ALS). Then the Spectral Angle Mapper-Orthogonal Projection (SAM-OP) algorithm revealed whether references actually occur in the mapped media powders. Finally, a quantification was provided by Classical Least Squares (CLS) modelling. Quantities of 18 significant amino acids mostly correlated with the reference method. The proposed method can be generally applied even for such complicated samples. Leveraging Raman mapping and innovative chemometric methods enhance recombinant protein production by improving the understanding of the spatial distribution and composition of cell culture media in mammalian cell cultivations.
Collapse
Affiliation(s)
- Edit Hirsch
- Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Müegyetem rkp. 3., H-1111 Budapest, Hungary
| | - Zsuzsanna Bornemissza
- Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Müegyetem rkp. 3., H-1111 Budapest, Hungary
| | - Zsombor K Nagy
- Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Müegyetem rkp. 3., H-1111 Budapest, Hungary
| | - György J Marosi
- Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Müegyetem rkp. 3., H-1111 Budapest, Hungary
| | - Attila Farkas
- Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Müegyetem rkp. 3., H-1111 Budapest, Hungary.
| |
Collapse
|
2
|
Lezin C, Mauduit P, Uzan G, Abdelgawad ME. An Evaluation of Different Types of Peptone as Partial Substitutes for Animal-derived Serum in Vero Cell Culture. Altern Lab Anim 2022; 50:339-348. [PMID: 36062749 DOI: 10.1177/02611929221122780] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Vero cells are one of the most frequently used cell types in virology. They can be used not only as a vehicle for the replication of viruses, but also as a model for investigating viral infectivity, cytopathology and vaccine production. There is increasing awareness of the need to limit the use of animal-derived components in cell culture media for a number of reasons, which include reducing the risk of contamination and decreasing costs related to the downstream processing of commercial products obtained via cell culture. The current study evaluates the use of protein hydrolysates (PHLs), also known as peptones, as partial substitutes for fetal bovine serum (FBS) in Vero cell culture. Eleven plant-based, two yeast-based, and three casein-based peptones were assessed, with different batches evaluated in the study. We tested the effects of three concentration ratios of FBS and peptone on Vero cell proliferation, four days after the initial cell seeding. Some of the tested peptones, when in combination with a minimal 1% level of FBS, supported cell proliferation rates equivalent to those achieved with 10% FBS. Collectively, our findings showed that plant-based peptones could represent promising options for the successful formulation of serum-reduced cell culture media for vaccine production. This is especially relevant in the context of the current COVID-19 pandemic, in view of the urgent need for SARS-CoV-2 virus production for certain types of vaccine. The current study contributes to the Three Rs principle of reduction, as well as addressing animal ethics concerns associated with FBS, by repurposing PHLs for use in cell culture.
Collapse
Affiliation(s)
- Chloe Lezin
- UMR-S-MD 1197, 27102Inserm, Villejuif, France.,Paris-Saclay University, Villejuif, France.,Organotechnie, R&D Department, La Courneuve, France
| | - Philippe Mauduit
- UMR-S-MD 1197, 27102Inserm, Villejuif, France.,Paris-Saclay University, Villejuif, France
| | - Georges Uzan
- UMR-S-MD 1197, 27102Inserm, Villejuif, France.,Paris-Saclay University, Villejuif, France
| | - Mohamed Essameldin Abdelgawad
- Biochemistry & Molecular Biotechnology Division, Chemistry Department, Faculty of Science, Helwan University, Cairo, Egypt.,Innovative Cellular Microenvironment Optimization Platform (ICMOP), Helwan University, Cairo, Egypt.,Precision Therapy Unit, Helwan University, Cairo, Egypt
| |
Collapse
|
3
|
Bandyopadhyay A, Kosanam H, Yang RS, Gupta B, Naralakattu N, Pakhale S, Kress J, Richardson D, Ly J. Low-molecular-weight impurity in Poloxamer 188 responsible for atypical cell culture performance for mAb production. J Biotechnol 2022; 351:13-22. [PMID: 35483475 DOI: 10.1016/j.jbiotec.2022.04.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2022] [Revised: 04/12/2022] [Accepted: 04/21/2022] [Indexed: 11/26/2022]
Abstract
During a recent manufacturing campaign for a monoclonal antibody using a fed-batch process, poor cell culture performance was observed across two manufacturing sites with similar scales and equipment. Root cause analysis indicated that the poor cell culture performance was linked to the production basal media. Genealogy of the precursor raw materials used in the media revealed that a particular lot of Poloxamer 188 (P188) was the common link to the poor-performing media lots. P188 serves a critical role in protecting cells against shear in cell culture bioprocesses. However, the small-scale studies suggested that the poor cell culture performance was cytostatic in nature rather than being caused due to lack of shear protection. Several P188 lots were tested analytically using SEC-MS and RP-LC-MS methods and a unique low molecular weight species was identified in the suspect lot of poloxamer. The impurity was identified to be polypropylene oxide (PPO), a reaction intermediate in P188 synthesis. Spiking studies with PPO further confirmed its cytostatic nature. This case study highlights yet another scenario where lot-to-lot variability continues to impact bioprocesses and re-emphasizes the need for robust analytical and cell-culture raw material screening methods.
Collapse
Affiliation(s)
- Arpan Bandyopadhyay
- Biologics Process Development and Commercialization, Merck & Co., Inc, Kenilworth, New Jersey 07033, United States
| | - Hari Kosanam
- Vaccines Process Development and Commercialization, Merck & Co., Inc, Westpoint, Pennsylvania 19486, United States
| | - Rong-Sheng Yang
- Analytical Research & Development, Merck & Co., Inc, Kenilworth, New Jersey 07033, United States
| | - Balrina Gupta
- Biologics Upstream Process Development, Merck & Co., Inc, Kenilworth, New Jersey 07033, United States
| | - Naja Naralakattu
- Global Technical Operations - Raw Materials Center of Excellence, Merck & Co., Inc, Westpoint, Pennsylvania 19486, United States
| | - Shital Pakhale
- Biologics Process Development and Commercialization, Merck & Co., Inc, Kenilworth, New Jersey 07033, United States
| | - Jared Kress
- Vaccines Process Development and Commercialization, Merck & Co., Inc, Westpoint, Pennsylvania 19486, United States
| | - Douglas Richardson
- Analytical Research & Development, Merck & Co., Inc, Kenilworth, New Jersey 07033, United States
| | - Jeffrey Ly
- Biologics Process Development and Commercialization, Merck & Co., Inc, Kenilworth, New Jersey 07033, United States
| |
Collapse
|
4
|
Combe M, Sokolenko S. Quantifying the impact of cell culture media on CHO cell growth and protein production. Biotechnol Adv 2021; 50:107761. [PMID: 33945850 DOI: 10.1016/j.biotechadv.2021.107761] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2020] [Revised: 04/22/2021] [Accepted: 04/24/2021] [Indexed: 10/21/2022]
Abstract
In recombinant protein production, cell culture media development and optimization is typically seen as a useful strategy to increase titer and cell density, reduce by-products, as well as improve product quality (with cell density and titer often serving as the primary reported outcome of media studies). However, despite the large number of media optimization studies, there have been few attempts to comprehensively assess the overall effectiveness of media additives. The aim of this review is therefore both to document published media optimization studies over the last twenty years (in the context of Chinese hamster ovary cell recombinant production) and quantitatively estimate the impact of this media optimization on cell culture performance. In considering 78 studies, we have identified 238 unique media components that have been supplemented over the last 20 years. Among these additives, trace elements stood out as having a positive impact on cell density while nucleotides show potential for increasing titer, with commercial supplements benefiting both. However, we also identified that the impact of specific additives is far more variable than often perceived. With relatively few media studies considering multiple cell lines or multiple basal media, teasing out consistent and general trends becomes a considerable challenge. By extracting cell density and titer values from all of the reviewed studies, we were able to build a mixed-effect model capable of estimating the relative impact of additives, cell line, product type, basal medium, cultivation method (flask or reactor), and feeding strategy (batch or fed-batch). Overall, additives only accounted for 3% of the variation in cell density and 1% of the variation in titer. Similarly, the impact of basal media was also relatively modest, at 10% for cell density and 0% for titer. Cell line, product type, and feeding strategy were all found to have more impact. These results emphasize the need for media studies to consider more factors to ensure that reported observations can be generalized and further developed.
Collapse
Affiliation(s)
- Michelle Combe
- Department of Process Engineering and Applied Science, Dalhousie University, 1360 Barrington St., PO Box 15000, Halifax, NS B3H 4R2, Canada
| | - Stanislav Sokolenko
- Department of Process Engineering and Applied Science, Dalhousie University, 1360 Barrington St., PO Box 15000, Halifax, NS B3H 4R2, Canada.
| |
Collapse
|
5
|
Djemal L, von Hagen J, Kolmar H, Deparis V. Characterization of soy protein hydrolysates and influence of its iron content on monoclonal antibody production by a murine hybridoma cell line. Biotechnol Prog 2021; 37:e3147. [PMID: 33742790 DOI: 10.1002/btpr.3147] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2021] [Revised: 02/23/2021] [Accepted: 03/16/2021] [Indexed: 11/12/2022]
Abstract
A challenging aspect with the use of protein hydrolysates in commercial manufacturing processes of recombinant therapeutic proteins is their impacts on the protein production due to a lack of understanding of batch-to-batch variability. Soy hydrolysates variability and its impact on fed-batch production of a recombinant monoclonal antibody (mAb) expressed in Sp2/0 cells were studied using 37 batches from the same vendor. The batch-to-batch variability of soy hydrolysates impacted cell growth, titer and product quality. Physicochemical characterization of batches confirmed that soy hydrolysates are mainly a source of amino acids and peptides containing lower amounts of other components such as carbohydrates and chemical elements in cell culture media. Soy hydrolysates composition of different batches was consistent except for trace elements. Statistical analyses identified iron as a potential marker of a poor process performance. To verify this correlation, two forms of iron, ferric ammonium citrate and ferrous sulfate, were added to a batch of soy hydrolysates associated to a low level of iron during cell culture. Both forms of iron reduced significantly cell growth, mAb titer and increased level of the acidic charge variants of the mAb. Consequently, trace element composition of soy hydrolysates or of all incoming raw materials might lead to significant impacts on process performance and product quality and therefore need to be tightly controlled.
Collapse
Affiliation(s)
- Leïla Djemal
- Manufacturing Science and Technology, Heathcare, Merck KGaA, Corsier-sur-Vevey, Switzerland.,Department of Applied Biochemistry, Technical University of Darmstadt, Darmstadt, Germany
| | | | - Harald Kolmar
- Department of Applied Biochemistry, Technical University of Darmstadt, Darmstadt, Germany
| | - Véronique Deparis
- Manufacturing Science and Technology, Heathcare, Merck KGaA, Corsier-sur-Vevey, Switzerland
| |
Collapse
|
6
|
Tang P, Xu J, Louey A, Tan Z, Yongky A, Liang S, Li ZJ, Weng Y, Liu S. Kinetic modeling of Chinese hamster ovary cell culture: factors and principles. Crit Rev Biotechnol 2020; 40:265-281. [DOI: 10.1080/07388551.2019.1711015] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Affiliation(s)
- Peifeng Tang
- Department of Paper and Bioprocess Engineering, SUNY-ESF, Syracuse, NY, USA
- Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA
| | - Jianlin Xu
- Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA
| | - Alastair Louey
- Elpiscience Biopharma, Cayman Islands George Town, Grand Cayman, UK
| | - Zhijun Tan
- Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA
| | - Andrew Yongky
- Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA
| | - Shaoyan Liang
- Department of Molecular Biophysics & Biochemistry, Yale University, New Haven, CT, USA
| | - Zheng Jian Li
- Global Product Development and Supply, Bristol-Myers Squibb Company, Devens, MA, USA
| | - Yongyan Weng
- Department of Civil Engineering, University of Nottingham, Nottingham, UK
| | - Shijie Liu
- Department of Paper and Bioprocess Engineering, SUNY-ESF, Syracuse, NY, USA
| |
Collapse
|
7
|
Floris P, McGillicuddy N, Morrissey B, Albrecht S, Kaisermayer C, Hawe D, Riordan L, Lindeberg A, Forestell S, Bones J. A LC–MS/MS platform for the identification of productivity markers in industrial mammalian cell culture media. Process Biochem 2019. [DOI: 10.1016/j.procbio.2019.08.014] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
8
|
Narayanappa AT, Mwilu S, Holdread S, Hammett K, Bu G, Dodson EC, Brooks JW. A rapid cell-based assay for determining poloxamer quality in CHO suspension cell culture. Biotechniques 2019; 67:98-109. [PMID: 31347927 DOI: 10.2144/btn-2019-0070] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Poloxamers are water-soluble polymers that are widely used in cell culture bioprocessing to protect cells against shearing forces. Use of poor-quality poloxamers may lead to a drastic reduction in cell growth, viabilities and productivities in cell culture-based manufacturing. In order to evaluate poloxamer quality and promote more consistent performance, a rapid cell membrane adhesion to hydrocarbon assay was developed based on the adhesive properties of cell membranes to selective hydrocarbons. The assay can identify a poor-performing poloxamer characterized by significant drop in viable cell density and percent viability. The assay was verified across multiple good and bad poloxamer lots, and the results were in agreement with established cell growth and high-performance liquid chromatography assays.
Collapse
Affiliation(s)
| | - Sam Mwilu
- Advanced Bioprocessing, Thermo Fisher Scientific, 250 Schilling Circle, Hunt Valley, MD 21030, USA
| | - Stacy Holdread
- Advanced Bioprocessing, Thermo Fisher Scientific, 250 Schilling Circle, Hunt Valley, MD 21030, USA
| | - Kimesha Hammett
- Advanced Bioprocessing, Thermo Fisher Scientific, 250 Schilling Circle, Hunt Valley, MD 21030, USA
| | - George Bu
- Advanced Bioprocessing, Thermo Fisher Scientific, 250 Schilling Circle, Hunt Valley, MD 21030, USA
| | - Elizabeth C Dodson
- Advanced Bioprocessing, Thermo Fisher Scientific, 250 Schilling Circle, Hunt Valley, MD 21030, USA
| | - James W Brooks
- Advanced Bioprocessing, Thermo Fisher Scientific, 250 Schilling Circle, Hunt Valley, MD 21030, USA
| |
Collapse
|
9
|
Dickens J, Khattak S, Matthews TE, Kolwyck D, Wiltberger K. Biopharmaceutical raw material variation and control. Curr Opin Chem Eng 2018. [DOI: 10.1016/j.coche.2018.10.007] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
10
|
McGillicuddy N, Floris P, Albrecht S, Bones J. Examining the sources of variability in cell culture media used for biopharmaceutical production. Biotechnol Lett 2017; 40:5-21. [DOI: 10.1007/s10529-017-2437-8] [Citation(s) in RCA: 36] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2017] [Accepted: 09/07/2017] [Indexed: 12/15/2022]
|
11
|
Buckley K, Ryder AG. Applications of Raman Spectroscopy in Biopharmaceutical Manufacturing: A Short Review. APPLIED SPECTROSCOPY 2017; 71:1085-1116. [PMID: 28534676 DOI: 10.1177/0003702817703270] [Citation(s) in RCA: 76] [Impact Index Per Article: 10.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
The production of active pharmaceutical ingredients (APIs) is currently undergoing its biggest transformation in a century. The changes are based on the rapid and dramatic introduction of protein- and macromolecule-based drugs (collectively known as biopharmaceuticals) and can be traced back to the huge investment in biomedical science (in particular in genomics and proteomics) that has been ongoing since the 1970s. Biopharmaceuticals (or biologics) are manufactured using biological-expression systems (such as mammalian, bacterial, insect cells, etc.) and have spawned a large (>€35 billion sales annually in Europe) and growing biopharmaceutical industry (BioPharma). The structural and chemical complexity of biologics, combined with the intricacy of cell-based manufacturing, imposes a huge analytical burden to correctly characterize and quantify both processes (upstream) and products (downstream). In small molecule manufacturing, advances in analytical and computational methods have been extensively exploited to generate process analytical technologies (PAT) that are now used for routine process control, leading to more efficient processes and safer medicines. In the analytical domain, biologic manufacturing is considerably behind and there is both a huge scope and need to produce relevant PAT tools with which to better control processes, and better characterize product macromolecules. Raman spectroscopy, a vibrational spectroscopy with a number of useful properties (nondestructive, non-contact, robustness) has significant potential advantages in BioPharma. Key among them are intrinsically high molecular specificity, the ability to measure in water, the requirement for minimal (or no) sample pre-treatment, the flexibility of sampling configurations, and suitability for automation. Here, we review and discuss a representative selection of the more important Raman applications in BioPharma (with particular emphasis on mammalian cell culture). The review shows that the properties of Raman have been successfully exploited to deliver unique and useful analytical solutions, particularly for online process monitoring. However, it also shows that its inherent susceptibility to fluorescence interference and the weakness of the Raman effect mean that it can never be a panacea. In particular, Raman-based methods are intrinsically limited by the chemical complexity and wide analyte-concentration-profiles of cell culture media/bioprocessing broths which limit their use for quantitative analysis. Nevertheless, with appropriate foreknowledge of these limitations and good experimental design, robust analytical methods can be produced. In addition, new technological developments such as time-resolved detectors, advanced lasers, and plasmonics offer potential of new Raman-based methods to resolve existing limitations and/or provide new analytical insights.
Collapse
Affiliation(s)
- Kevin Buckley
- Nanoscale Biophotonics Laboratory, School of Chemistry, National University of Ireland - Galway, Galway, Ireland
| | - Alan G Ryder
- Nanoscale Biophotonics Laboratory, School of Chemistry, National University of Ireland - Galway, Galway, Ireland
| |
Collapse
|
12
|
Trunfio N, Lee H, Starkey J, Agarabi C, Liu J, Yoon S. Characterization of mammalian cell culture raw materials by combining spectroscopy and chemometrics. Biotechnol Prog 2017; 33:1127-1138. [PMID: 28393480 PMCID: PMC5573913 DOI: 10.1002/btpr.2480] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2016] [Revised: 02/06/2017] [Indexed: 11/06/2022]
Abstract
Two of the primary issues with characterizing the variability of raw materials used in mammalian cell culture, such as wheat hydrolysate, is that the analyses of these materials can be time consuming, and the results of the analyses are not straightforward to interpret. To solve these issues, spectroscopy can be combined with chemometrics to provide a quick, robust and easy to understand methodology for the characterization of raw materials; which will improve cell culture performance by providing an assessment of the impact that a given raw material will have on final product quality. In this study, four spectroscopic technologies: near infrared spectroscopy, middle infrared spectroscopy, Raman spectroscopy, and fluorescence spectroscopy were used in conjunction with principal component analysis to characterize the variability of wheat hydrolysates, and to provide evidence that the classification of good and bad lots of raw material is possible. Then, the same spectroscopic platforms are combined with partial least squares regressions to quantitatively predict two cell culture critical quality attributes (CQA): integrated viable cell density and IgG titer. The results showed that near infrared (NIR) spectroscopy and fluorescence spectroscopy are capable of characterizing the wheat hydrolysate's chemical structure, with NIR performing slightly better; and that they can be used to estimate the raw materials' impact on the CQAs. These results were justified by demonstrating that of all the components present in the wheat hydrolysates, six amino acids: arginine, glycine, phenylalanine, tyrosine, isoleucine and threonine; and five trace elements: copper, phosphorus, molybdenum, arsenic and aluminum, had a large, statistically significant effect on the CQAs, and that NIR and fluorescence spectroscopy performed the best for characterizing the important amino acids. It was also found that the trace elements of interest were not characterized well by any of the spectral technologies used; however, the trace elements were also shown to have a less significant effect on the CQAs than the amino acids. © 2017 The Authors Biotechnology Progress published by Wiley Periodicals, Inc. on behalf of American Institute of Chemical Engineers, 33:1127-1138, 2017.
Collapse
Affiliation(s)
- Nicholas Trunfio
- Dept. of Chemical Engineering, University of Massachusetts, Lowell, MA, USA
| | - Haewoo Lee
- Dept. of Chemical Engineering, University of Massachusetts, Lowell, MA, USA
| | | | - Cyrus Agarabi
- Div. II, Office of Biotechnology Products, Office of Pharmaceutical Quality, CDER, FDA, Silver Spring, MD, USA
| | - Jay Liu
- Dept. of Chemical Engineering, Pukyung National University, Busan, Nam-Gu, Korea
| | - Seongkyu Yoon
- Dept. of Chemical Engineering, University of Massachusetts, Lowell, MA, USA
| |
Collapse
|
13
|
Takagi Y, Kikuchi T, Wada R, Omasa T. The enhancement of antibody concentration and achievement of high cell density CHO cell cultivation by adding nucleoside. Cytotechnology 2017; 69:511-521. [PMID: 28251404 DOI: 10.1007/s10616-017-0066-7] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2016] [Accepted: 01/05/2017] [Indexed: 01/05/2023] Open
Abstract
Recently, with the dramatic increase in demand for therapeutic antibodies, Chinese hamster ovary (CHO) cell culture systems have made significant progress in recombinant antibody production. Over the past two decades, recombinant antibody productivity has been improved by more than 100-fold. Medium optimization has been identified as an important key approach for increasing product concentrations. In this study, we evaluated the effects of deoxyuridine addition to fed-batch cultures of antibody-expressing CHO cell lines. Furthermore, we investigated the effects of combined addition of deoxyuridine, thymidine, and deoxycytidine. Our results suggest that addition of these pyrimidine nucleosides can increase CHO cell growth, with no significant change in the specific production rate. As a result of the increased cell growth, the antibody concentration was elevated and we were able to achieve more than 9 g/L during 16 days of culture. Similar effects of nucleoside addition were observed in fed-batch cultures of a Fab fragment-expressing CHO cell line, and the final Fab fragment concentration was more than 4 g/L. This nucleoside addition strategy could be a powerful platform for efficient antibody production.
Collapse
Affiliation(s)
- Yasuhiro Takagi
- Institute of Bioscience and Bioindustry, Tokushima University, 2-1 Minamijosanjima-cho, Tokushima, 770-8506, Japan
- Biotechnology Laboratories, Astellas Pharma Inc., 5-2-3 Tokodai, Tsukuba, Ibaraki, 300-2698, Japan
| | - Takuya Kikuchi
- Biotechnology Laboratories, Astellas Pharma Inc., 5-2-3 Tokodai, Tsukuba, Ibaraki, 300-2698, Japan
| | - Ryuta Wada
- Biotechnology Laboratories, Astellas Pharma Inc., 5-2-3 Tokodai, Tsukuba, Ibaraki, 300-2698, Japan
| | - Takeshi Omasa
- Institute of Bioscience and Bioindustry, Tokushima University, 2-1 Minamijosanjima-cho, Tokushima, 770-8506, Japan.
- Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka, 565-0871, Japan.
| |
Collapse
|
14
|
Implementation of Quality by Design for processing of food products and biotherapeutics. FOOD AND BIOPRODUCTS PROCESSING 2016. [DOI: 10.1016/j.fbp.2016.05.009] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
15
|
McElearney K, Ali A, Gilbert A, Kshirsagar R, Zang L. Tryptophan oxidation catabolite,N-formylkynurenine, in photo degraded cell culture medium results in reduced cell culture performance. Biotechnol Prog 2015; 32:74-82. [DOI: 10.1002/btpr.2198] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2015] [Revised: 10/24/2015] [Indexed: 12/14/2022]
Affiliation(s)
- Kyle McElearney
- Cell Culture Development, Biogen; 225 Binney Street Cambridge MA 02142
| | - Amr Ali
- Cell Culture Development, Biogen; 225 Binney Street Cambridge MA 02142
| | - Alan Gilbert
- Cell Culture Development, Biogen; 225 Binney Street Cambridge MA 02142
| | - Rashmi Kshirsagar
- Cell Culture Development, Biogen; 225 Binney Street Cambridge MA 02142
| | - Li Zang
- Analytical Development, Biogen; 225 Binney Street Cambridge MA 02142
| |
Collapse
|
16
|
Sokolov M, Soos M, Neunstoecklin B, Morbidelli M, Butté A, Leardi R, Solacroup T, Stettler M, Broly H. Fingerprint detection and process prediction by multivariate analysis of fed-batch monoclonal antibody cell culture data. Biotechnol Prog 2015; 31:1633-44. [DOI: 10.1002/btpr.2174] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2015] [Revised: 07/24/2015] [Indexed: 01/05/2023]
Affiliation(s)
- Michael Sokolov
- Dept. of Chemistry and Applied Biosciences, ETH Zurich; Institute of Chemical and Bioengineering; Zurich Switzerland
| | - Miroslav Soos
- Dept. of Chemistry and Applied Biosciences, ETH Zurich; Institute of Chemical and Bioengineering; Zurich Switzerland
| | - Benjamin Neunstoecklin
- Dept. of Chemistry and Applied Biosciences, ETH Zurich; Institute of Chemical and Bioengineering; Zurich Switzerland
| | - Massimo Morbidelli
- Dept. of Chemistry and Applied Biosciences, ETH Zurich; Institute of Chemical and Bioengineering; Zurich Switzerland
| | - Alessandro Butté
- Dept. of Chemistry and Applied Biosciences, ETH Zurich; Institute of Chemical and Bioengineering; Zurich Switzerland
| | | | - Thomas Solacroup
- Biotech Process Sciences; Merck Serono S.A.; Corsier-sur-Vevey Switzerland
| | - Matthieu Stettler
- Biotech Process Sciences; Merck Serono S.A.; Corsier-sur-Vevey Switzerland
| | - Hervé Broly
- Biotech Process Sciences; Merck Serono S.A.; Corsier-sur-Vevey Switzerland
| |
Collapse
|
17
|
Kishishita S, Katayama S, Kodaira K, Takagi Y, Matsuda H, Okamoto H, Takuma S, Hirashima C, Aoyagi H. Optimization of chemically defined feed media for monoclonal antibody production in Chinese hamster ovary cells. J Biosci Bioeng 2015; 120:78-84. [DOI: 10.1016/j.jbiosc.2014.11.022] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2014] [Revised: 11/21/2014] [Accepted: 11/25/2014] [Indexed: 12/11/2022]
|
18
|
Gupta AJ, Wierenga PA, Gruppen H, Boots JW. Influence of protein and carbohydrate contents of soy protein hydrolysates on cell density and IgG production in animal cell cultures. Biotechnol Prog 2015; 31:1396-405. [DOI: 10.1002/btpr.2121] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2015] [Revised: 05/26/2015] [Indexed: 11/09/2022]
Affiliation(s)
- Abhishek J. Gupta
- Laboratory of Food Chemistry; Wageningen University; Wageningen The Netherlands
- FrieslandCampina Domo; Amersfoort The Netherlands
| | - Peter A. Wierenga
- Laboratory of Food Chemistry; Wageningen University; Wageningen The Netherlands
| | - Harry Gruppen
- Laboratory of Food Chemistry; Wageningen University; Wageningen The Netherlands
| | | |
Collapse
|
19
|
Richardson J, Shah B, Bondarenko PV, Bhebe P, Zhang Z, Nicklaus M, Kombe MC. Metabolomics analysis of soy hydrolysates for the identification of productivity markers of mammalian cells for manufacturing therapeutic proteins. Biotechnol Prog 2015; 31:522-31. [DOI: 10.1002/btpr.2050] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2014] [Revised: 12/17/2014] [Indexed: 12/12/2022]
Affiliation(s)
- Jason Richardson
- Process Development; Amgen, Inc; One Amgen Center Drive Thousand Oaks CA 91320
| | - Bhavana Shah
- Process Development; Amgen, Inc; One Amgen Center Drive Thousand Oaks CA 91320
| | - Pavel V. Bondarenko
- Process Development; Amgen, Inc; One Amgen Center Drive Thousand Oaks CA 91320
| | - Prince Bhebe
- Process Development; Amgen, Inc; One Amgen Center Drive Thousand Oaks CA 91320
| | - Zhongqi Zhang
- Process Development; Amgen, Inc; One Amgen Center Drive Thousand Oaks CA 91320
| | - Michele Nicklaus
- Process Development; Amgen Inc; 4000 Nelson Road Longmont CO 80503
| | - Maua C. Kombe
- Process Development; Amgen Inc; 4000 Nelson Road Longmont CO 80503
| |
Collapse
|
20
|
|
21
|
Peng H, Hall KM, Clayton B, Wiltberger K, Hu W, Hughes E, Kane J, Ney R, Ryll T. Development of small scale cell culture models for screening poloxamer 188 lot-to-lot variation. Biotechnol Prog 2014; 30:1411-8. [DOI: 10.1002/btpr.1967] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2014] [Revised: 06/20/2014] [Indexed: 12/12/2022]
Affiliation(s)
- Haofan Peng
- Cell Culture Development, Biogen Idec; Research Triangle Park; 5000 Davis Drive NC 27709
| | - Kaitlyn M. Hall
- Cell Culture Development, Biogen Idec; Research Triangle Park; 5000 Davis Drive NC 27709
| | - Blake Clayton
- Cell Culture Development, Biogen Idec; Research Triangle Park; 5000 Davis Drive NC 27709
| | - Kelly Wiltberger
- Cell Culture Development, Biogen Idec; Research Triangle Park; 5000 Davis Drive NC 27709
| | - Weiwei Hu
- Cell Culture Development, Biogen Idec; Research Triangle Park; 5000 Davis Drive NC 27709
| | - Erik Hughes
- Manufacturing Sciences, Biogen Idec; Research Triangle Park; NC 27709
| | - John Kane
- Manufacturing Sciences, Biogen Idec; Research Triangle Park; NC 27709
| | - Rachel Ney
- Manufacturing Sciences, Biogen Idec; Research Triangle Park; NC 27709
| | - Thomas Ryll
- Cell Culture Development, Biogen Idec; Cambridge MA 02142
| |
Collapse
|
22
|
Farrell A, McLoughlin N, Milne JJ, Marison IW, Bones J. Application of Multi-Omics Techniques for Bioprocess Design and Optimization in Chinese Hamster Ovary Cells. J Proteome Res 2014; 13:3144-59. [DOI: 10.1021/pr500219b] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Affiliation(s)
- Amy Farrell
- Characterisation
and Comparability Laboratory, NIBRT − The National Institute for Bioprocessing Research and Training, Foster Avenue, Mount Merrion, Blackrock, Co. Dublin, Ireland
| | - Niaobh McLoughlin
- Characterisation
and Comparability Laboratory, NIBRT − The National Institute for Bioprocessing Research and Training, Foster Avenue, Mount Merrion, Blackrock, Co. Dublin, Ireland
| | - John J. Milne
- Characterisation
and Comparability Laboratory, NIBRT − The National Institute for Bioprocessing Research and Training, Foster Avenue, Mount Merrion, Blackrock, Co. Dublin, Ireland
| | - Ian W. Marison
- Laboratory
of Integrated Bioprocessing, Dublin City University, Glasnevin, Dublin 9, Ireland
| | - Jonathan Bones
- Characterisation
and Comparability Laboratory, NIBRT − The National Institute for Bioprocessing Research and Training, Foster Avenue, Mount Merrion, Blackrock, Co. Dublin, Ireland
| |
Collapse
|
23
|
Gupta AJ, Hageman JA, Wierenga PA, Boots JW, Gruppen H. Chemometric analysis of soy protein hydrolysates used in animal cell culture for IgG production – An untargeted metabolomics approach. Process Biochem 2014. [DOI: 10.1016/j.procbio.2013.10.013] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
24
|
Gupta AJ, Gruppen H, Maes D, Boots JW, Wierenga PA. Factors causing compositional changes in soy protein hydrolysates and effects on cell culture functionality. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2013; 61:10613-10625. [PMID: 24117369 DOI: 10.1021/jf403051z] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Soy protein hydrolysates significantly enhance cell growth and recombinant protein production in cell cultures. The extent of this enhancement in cell growth and IgG production is known to vary from batch to batch. This can be due to differences in the abundance of different classes of compounds (e.g., peptide content), the quality of these compounds (e.g., glycated peptides), or the presence of specific compounds (e.g., furosine). These quantitative and qualitative differences between batches of hydrolysates result from variation in the seed composition and seed/meal processing. Although a considerable amount of literature is available that describes these factors, this knowledge has not been combined in an overview yet. The aim of this review is to identify the most dominant factors that affect hydrolysate composition and functionality. Although there is a limited influence of variation in the seed composition, the overview shows that the qualitative changes in hydrolysate composition result in the formation of minor compounds (e.g., Maillard reaction products). In pure systems, these compounds have a profound effect on the cell culture functionality. This suggests that the presence of these compounds in soy protein hydrolysates may affect hydrolysate functionality as well. This influence on the functionality can be of direct or indirect nature. For instance, some minor compounds (e.g., Maillard reaction products) are cytotoxic, whereas other compounds (e.g., phytates) suppress protein hydrolysis during hydrolysate production, resulting in altered peptide composition, and, thus, affect the functionality.
Collapse
Affiliation(s)
- Abhishek J Gupta
- Laboratory of Food Chemistry, Wageningen University , P.O. Box 17, 6700 AA Wageningen, The Netherlands
| | | | | | | | | |
Collapse
|
25
|
Gilbert A, McElearney K, Kshirsagar R, Sinacore MS, Ryll T. Investigation of metabolic variability observed in extended fed batch cell culture. Biotechnol Prog 2013; 29:1519-27. [DOI: 10.1002/btpr.1787] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2013] [Revised: 07/23/2013] [Indexed: 12/31/2022]
Affiliation(s)
- Alan Gilbert
- Cell Culture Development, Biogen Idec; Cambridge MA 02142
| | | | | | | | - Thomas Ryll
- Cell Culture Development, Biogen Idec; Cambridge MA 02142
| |
Collapse
|
26
|
Mercier SM, Diepenbroek B, Dalm MC, Wijffels RH, Streefland M. Multivariate data analysis as a PAT tool for early bioprocess development data. J Biotechnol 2013; 167:262-70. [DOI: 10.1016/j.jbiotec.2013.07.006] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2013] [Revised: 07/03/2013] [Accepted: 07/08/2013] [Indexed: 11/26/2022]
|
27
|
Hakemeyer C, Strauss U, Werz S, Folque F, Menezes JC. Near-infrared and two-dimensional fluorescence spectroscopy monitoring of monoclonal antibody fermentation media quality: Aged media decreases cell growth. Biotechnol J 2013; 8:835-46. [DOI: 10.1002/biot.201200355] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2012] [Revised: 03/05/2013] [Accepted: 04/15/2013] [Indexed: 11/07/2022]
|
28
|
Quality by design for biopharmaceuticals: a historical review and guide for implementation. ACTA ACUST UNITED AC 2013. [DOI: 10.4155/pbp.13.6] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
29
|
Li G, Wen ZQ. Screening soy hydrolysates for the production of a recombinant therapeutic protein in commercial cell line by combined approach of near-infrared spectroscopy and chemometrics. Appl Microbiol Biotechnol 2013; 97:2653-60. [DOI: 10.1007/s00253-013-4694-3] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2012] [Revised: 01/01/2013] [Accepted: 01/03/2013] [Indexed: 11/29/2022]
|
30
|
Luo Y, Pierce KM. Development toward rapid and efficient screening for high performance hydrolysate lots in a recombinant monoclonal antibody manufacturing process. Biotechnol Prog 2012; 28:1061-8. [PMID: 22641483 DOI: 10.1002/btpr.1568] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2012] [Revised: 05/08/2012] [Indexed: 12/11/2022]
Abstract
Plant-derived hydrolysates are widely used in mammalian cell culture media to increase yields of recombinant proteins and monoclonal antibodies (mAbs). However, these chemically varied and undefined raw materials can have negative impact on yield and/or product quality in large-scale cell culture processes. Traditional methods that rely on fractionation of hydrolysates yielded little success in improving hydrolysate quality. We took a holistic approach to develop an efficient and reliable method to screen intact soy hydrolysate lots for commercial recombinant mAb manufacturing. Combined high-resolution (1) H nuclear magnetic resonance (NMR) spectroscopy and partial least squares (PLS) analysis led to a prediction model between product titer and NMR fingerprinting of soy hydrolysate with cross-validated correlation coefficient R(2) of 0.87 and root-mean-squared-error of cross-validation RMSECV% of 11.2%. This approach screens for high performance hydrolysate lots, therefore ensuring process consistency and product quality in the mAb manufacturing process. Furthermore, PLS analysis was successful in discerning multiple markers (DL-lactate, soy saccharides, citrate and succinate) among hydrolysate components that positively and negatively correlate with titer. Interestingly, these markers correlate to the metabolic characteristics of some strains of taxonomically diverse lactic acid bacteria (LAB). Thus our findings indicate that LAB strains may exist during hydrolysate manufacturing steps and their biochemical activities may attribute to the titer enhancement effect of soy hydrolysates.
Collapse
Affiliation(s)
- Ying Luo
- Product and Process Development, Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA 91320, USA.
| | | |
Collapse
|
31
|
Abstract
BACKGROUND Healthcare providers use recombinant biologics such as monoclonal antibodies to treat a variety of serious illnesses. Manufacturing of approved biotechnology products is complex, and the quality of the resulting biologic is dependent on careful control of process inputs and operating conditions. Biosimilars, which are similar but not identical to innovator biologics, are entering regulatory evaluation, approval, and marketing in regions with biosimilar approval pathways. SCOPE AND FINDINGS This article describes the evaluation and potential impact of manufacturing process changes and biosimilar product development, and explores the similarities and distinctions between the two. Regulatory agencies generally require a comparability exercise following a manufacturing process change. This comparability is focused primarily on analytical characterization of the approved product before and after the manufacturing process change, with non-clinical and clinical confirmation required when determined necessary. When developing a biosimilar, the manufacturer does not have access to key information including the innovator manufacturer's cell line, cell culture conditions, purification procedures, and fill and finish processes. Further, the biosimilar manufacturer does not have access to information about the innovator manufacturer's product development history, including knowledge about the quality attributes of lots used in non-clinical and clinical development. We define the biosimilar manufacturer's lack of information as the knowledge gap. As a result, a biosimilarity exercise to compare a biosimilar to an approved innovator biologic requires a rigorous evaluation to ensure the safety and efficacy of the biosimilar. CONCLUSION Given the knowledge gap under which biosimilars are developed, data to establish biosimilarity should go beyond a simple comparability exercise.
Collapse
Affiliation(s)
- Jaymi F Lee
- Drug Product Development, Amgen Inc., Thousand Oaks, CA 91320, USA.
| | | | | |
Collapse
|
32
|
Lee HW, Christie A, Xu J, Yoon S. Data fusion-based assessment of raw materials in mammalian cell culture. Biotechnol Bioeng 2012; 109:2819-28. [DOI: 10.1002/bit.24548] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2012] [Revised: 03/29/2012] [Accepted: 04/25/2012] [Indexed: 11/07/2022]
|
33
|
Lee HW, Christie A, Liu JJ, Yoon S. Estimation of raw material performance in mammalian cell culture using near infrared spectra combined with chemometrics approaches. Biotechnol Prog 2012; 28:824-32. [DOI: 10.1002/btpr.1536] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2011] [Revised: 01/29/2012] [Indexed: 12/16/2022]
|
34
|
Chen XH, Lou WY, Zong MH, Smith TJ. Optimization of culture conditions to produce high yields of active Acetobacter sp. CCTCC M209061 cells for anti-Prelog reduction of prochiral ketones. BMC Biotechnol 2011; 11:110. [PMID: 22099947 PMCID: PMC3341575 DOI: 10.1186/1472-6750-11-110] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2011] [Accepted: 11/20/2011] [Indexed: 12/02/2022] Open
Abstract
Background Chiral alcohols are widely used in the synthesis of chiral pharmaceuticals, flavors and functional materials and appropriate whole-cell biocatalysts offer a highly enantioselective, minimally polluting route to these valuable compounds. The recently isolated strain Acetobacter sp. CCTCC M209061 showed exclusive anti-Prelog stereoselectivity for the reduction of prochiral ketones, but the low biomass has limited its commercialization and industrial applications. To tackle this problem, the effects of medium components and culture conditions on the strain's growth and reduction activity were explored. Results By using a one-at-a-time method and a central composite rotatable design (CCRD), the optimal medium and culture conditions were found to be as follows: glucose 8.26 g/L, fructose 2.50 g/L, soy peptone 83.92 g/L, MnSO4·H2O 0.088 g/L, pH 5.70, 30°C and 10% (v/v) inoculum. Under the above-mentioned conditions, the biomass after 30 h cultivation reached 1.10 ± 0.03 g/L, which was 9.5-fold higher than that obtained with basic medium. Also, the reduction activity towards 4'-chloroacetophenone was markedly enhanced to 39.49 ± 0.96 μmol/min/g from 29.34 ± 0.65 μmol/min/g, with the product e.e. being above 99%. Comparable improvements were also seen with the enantioselective bioreduction of 4-(trimethylsilyl)-3-butyn-2-one to the key pharmaceutical precursor (R) - 4-(trimethylsilyl)-3-butyn-2-ol. Conclusions The biomass and reduction activity of Acetobacter sp. CCTCC M209061 can be greatly enhanced through the optimization strategy. This facilitates use of the strain in the anti-Prelog stereoselective reduction of prochiral ketones to enantiopure chiral alcohols as building blocks for many industries.
Collapse
Affiliation(s)
- Xiao-Hong Chen
- Lab of Applied Biocatalysis, South China University of Technology, Guangzhou, 510640, China
| | | | | | | |
Collapse
|
35
|
Predicting mab product yields from cultivation media components, using near-infrared and 2D-fluorescence spectroscopies. Biotechnol Prog 2011; 27:1339-46. [DOI: 10.1002/btpr.638] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2011] [Revised: 04/14/2011] [Indexed: 11/07/2022]
|
36
|
Rathore AS, Bhushan N, Hadpe S. Chemometrics applications in biotech processes: A review. Biotechnol Prog 2011; 27:307-15. [DOI: 10.1002/btpr.561] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2010] [Revised: 12/01/2010] [Indexed: 11/06/2022]
|
37
|
Bradley SA, Ouyang A, Purdie J, Smitka TA, Wang T, Kaerner A. Fermentanomics: monitoring mammalian cell cultures with NMR spectroscopy. J Am Chem Soc 2010; 132:9531-3. [PMID: 20578691 DOI: 10.1021/ja101962c] [Citation(s) in RCA: 67] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
As the number of therapeutic proteins produced by mammalian cell cultures in the pharmaceutical industry continues to increase, the need to improve productivity and ensure consistent product quality during process development activities becomes more significant. Rational medium design is known to improve cell culture performance, but an understanding of nutrient consumption and metabolite accumulation within the medium is required. To this end, we have developed a technique for using 1D (1)H NMR to quantitate nonprotein feed components and metabolites in mammalian cell cultures. We refer to the methodology as "Fermentanomics" to differentiate it from standard metabolomics. The method was found to generate spectra with excellent water suppression, signal-to-noise, and resolution. More importantly, nutrient consumption and metabolite accumulation was readily observed. In total, 50 media components have been identified and quantitated. The application of Fermentanomics to the optimization of a proprietary CHO basal medium yielded valuable insight regarding the nutrient levels needed to maintain productivity. While the focus here is on the extracellular milieu of CHO cell cultures, this methodology is generally applicable to quantitating intracellular concentrations and can be extended to other mammalian cell lines, as well as platforms such as yeasts, fungi, and Escherichia coli.
Collapse
Affiliation(s)
- Scott A Bradley
- Analytical Science Research and Development, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA
| | | | | | | | | | | |
Collapse
|
38
|
Kirdar AO, Chen G, Weidner J, Rathore AS. Application of near-infrared (NIR) spectroscopy for screening of raw materials used in the cell culture medium for the production of a recombinant therapeutic protein. Biotechnol Prog 2010; 26:527-31. [PMID: 19938040 DOI: 10.1002/btpr.329] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Control of raw materials based on an understanding of their impact on product attributes has been identified as a key aspect of developing a control strategy in the Quality by Design (QbD) paradigm. This article presents a case study involving use of a combined approach of Near-infrared (NIR) spectroscopy and Multivariate Data Analysis (MVDA) for screening of lots of basal medium powders based on their impact on process performance and product attributes. These lots had identical composition as per the supplier and were manufactured at different scales using an identical process. The NIR/MVDA analysis, combined with further investigation at the supplier site, concluded that grouping of medium components during the milling and blending process varied with the scale of production and media type. As a result, uniformity of blending, impurity levels, chemical compatibility, and/or heat sensitivity during the milling process for batches of large-scale media powder were deemed to be the source of variation as detected by NIR spectra. This variability in the raw materials was enough to cause unacceptably large variability in the performance of the cell culture step and impact the attributes of the resulting product. A combined NIR/MVDA approach made it possible to finger print the raw materials and distinguish between good and poor performing media lots.
Collapse
|
39
|
Ma N, Ellet J, Okediadi C, Hermes P, McCormick E, Casnocha S. A single nutrient feed supports both chemically defined NS0 and CHO fed-batch processes: Improved productivity and lactate metabolism. Biotechnol Prog 2010; 25:1353-63. [PMID: 19637321 DOI: 10.1002/btpr.238] [Citation(s) in RCA: 89] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
A chemically defined nutrient feed (CDF) coupled with basal medium preloading was developed to replace a hydrolysate-containing feed (HCF) for a fed-batch NS0 process. The CDF not only enabled a completely chemically defined process but also increased recombinant monoclonal antibody titer by 115%. Subsequent tests of CDF in a CHO process indicated that it could also replace the hydrolysate-containing nutrient feed in this expression system as well as providing an 80% increase in product titer. In both CDF NS0 and CHO processes, the peak lactate concentrations were lower and, more interestingly, lactate metabolism shifted markedly from net production to net consumption when cells transitioned from exponential to stationary growth phase. Subsequent investigations of the lactate metabolic shift in the CHO CDF process were carried out to identify the cause(s) of the metabolic shift. These investigations revealed several metabolic features of the CHO cell line that we studied. First, glucose consumption and lactate consumption are strictly complementary to each other. The combined cell specific glucose and lactate consumption rate was a constant across exponential and stationary growth phases. Second, Lactate dehydrogenase (LDH) activity fluctuated during the fed-batch process. LDH activity was at the lowest when lactate concentration started to decrease. Third, a steep cross plasma membrane glucose gradient exists. Intracellular glucose concentration was more than two orders of magnitude lower than that in the medium. Fourth, a large quantity of citrate was diverted out of mitochondria to the medium, suggesting a partially truncated tricarboxylic acid (TCA) cycle in CHO cells. Finally, other intermediates in or linked to the glycolytic pathway and the TCA cycle, which include alanine, citrate, isocitrate, and succinate, demonstrated a metabolic shift similar to that of lactate. Interestingly, all these metabolites are either in or linked to the pathway downstream of pyruvate, but upstream of fumarate in glucose metabolism. Although the specific mechanisms for the metabolic shift of lactate and other metabolites remain to be elucidated, the increased understanding of the metabolism of CHO cultures could lead to future improvements in medium and process development.
Collapse
Affiliation(s)
- Ningning Ma
- Bioprocess R&D, Global Biologics, Pfizer Inc, Chesterfield, MO 63017, USA.
| | | | | | | | | | | |
Collapse
|
40
|
Ducommun R, Favre MF, Carrard D, Fischer F. Outward electron transfer bySaccharomyces cerevisiaemonitored with a bi-cathodic microbial fuel cell-type activity sensor. Yeast 2009; 27:139-48. [DOI: 10.1002/yea.1738] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
|
41
|
Majors BS, Betenbaugh MJ, Pederson NE, Chiang GG. Enhancement of transient gene expression and culture viability using Chinese hamster ovary cells overexpressing Bcl-x(L). Biotechnol Bioeng 2008; 101:567-78. [PMID: 18727128 DOI: 10.1002/bit.21917] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Transient gene expression (TGE) provides a method for quickly delivering protein for research using mammalian cells. While high levels of recombinant proteins have been produced in TGE experiments in HEK 293 cells, TGE efforts in the commercially prominent CHO cell line still suffer from inadequate protein yields. Here, we describe a cell-engineering strategy to improve transient production of proteins using CHO cells. CHO-DG44 cells were engineered to overexpress the anti-apoptotic protein Bcl-x(L) and transiently transfected using polyethylenimine (PEI) in serum-free media. Pools and cell lines stably expressing Bcl-x(L) showed enhanced viable cell density and increased production of a glycosylated, therapeutic fusion protein in shake flask TGE studies. The improved cell lines showed fusion protein production levels ranging from 12.6 to 27.0 mg/L in the supernatant compared to the control cultures which produced 6.3-7.3 mg/L, representing a 70-270% increase in yield after 14 days of fed-batch culture. All Bcl-xL-expressing cell lines also exhibited an increase in specific productivity during the first 8 days of culture. In addition to increased production, Bcl-x(L) cell lines maintained viabilities above 90% and less apoptosis compared to the DG44 host which had viabilities below 60% after 14 days. Product quality was comparable between a Bcl-xL-engineered cell line and the CHO host. The work presented here provides the foundation for using anti-apoptosis engineered CHO cell lines for increased production of therapeutic proteins in TGE applications.
Collapse
Affiliation(s)
- Brian S Majors
- Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, 3400 North Charles Street, 221 Maryland Hall, Baltimore, Maryland 21218-2694, USA
| | | | | | | |
Collapse
|